Sign In
Buy VERO
$0.268
+0 (+0%)
At Close: Jul 02, 2026
Venus Concept Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Reaffirms Fiscal Year 2021 Revenue Guidance
04:05pm, Monday, 29'th Mar 2021
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:37pm, Monday, 22'nd Mar 2021
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept Inc. to Present at the H.C. Wainwright Annual Global LifeSciences Conference on March 9th
04:05pm, Thursday, 04'th Mar 2021
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that managemen
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management
Venus Concept to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 29, 2021
04:05pm, Monday, 08'th Feb 2021
TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
06:30am, Thursday, 14'th Jan 2021
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudi
Venus Concept Inc. to Present at Two Upcoming Investor Conferences in January
04:05pm, Tuesday, 05'th Jan 2021
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management
Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering
08:55am, Tuesday, 22'nd Dec 2020
TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of it
Venus Concept Inc. Announces Proposed Public Offering
04:05pm, Monday, 21'st Dec 2020
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends t
Venus Concept Announces Debt Refinancing
06:30am, Thursday, 10'th Dec 2020
New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future cash flow
Venus Concept to Host Virtual “Aesthetic & Hair Restoration Technology” Event on December 10th
04:05pm, Tuesday, 01'st Dec 2020
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
10:55am, Monday, 16'th Nov 2020
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
Venus Concept Announces Third Quarter and First Nine Months of 2020 Financial Results
07:30am, Monday, 16'th Nov 2020
TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for t
Venus Concept Inc. to Present at the Stifel 2020 Virtual Healthcare Conference
04:05pm, Tuesday, 03'rd Nov 2020
TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management
